Bleeding

BALTIMORE — Elagolix plus add-back of estradiol and norethindrone improved bleeding and non-bleeding symptoms linked to uterine fibroids among premenopausal women, according to researchers at the ACOG Annual Clinical & Scientific Meeting.

BALTIMORE — Patients with heavy menstrual bleeding who received the levonorgestrel 52 mg intrauterine device experienced significant and rapid decreases in uterine bleeding after placement, a researcher reported here.

Study results demonstrated no associations between SARS-CoV-2 vaccination and hospital admission or visit for postmenopausal bleeding and no association with premenopausal menstrual disturbance or bleeding.

Patients with CAD were no more likely to experience major bleeding or adverse CV events after transcatheter aortic valve replacement compared with patients without CAD, according to a post hoc analysis of data from the BRAVO-3 study.

Older adults with chronic kidney disease are at an increased risk for major hemorrhage, according to data published in Kidney International.

Among adults without CAD, the absolute risk for major bleeding with aspirin as primary prevention therapy exceeds the any absolute MI benefits for every level of atherosclerotic CVD risk, data from a meta-analysis show.

In a new analysis of the pooled cohort of the two STOPDAPT-2 trials of patients who had PCI, clopidogrel monotherapy after 1 month of dual antiplatelet therapy was associated with reduced bleeding risk regardless of diabetes status.

Patients who received apixaban or rivaroxaban after cardiac surgery were no more likely to experience major bleeding or thromboembolic events compared with patients who received warfarin after surgery, data from a single-center study show.

Routine use of over-the-scope clip as primary hemostasis did not decrease 30-day rebleeding compared with conventional therapy in patients with bleeding peptic ulcers at least 15 mm in size, according to research published in Gut.

An aspirin de-implementation intervention appeared associated with reduced bleeding risk patients hospitalized with atrial fibrillation and/or venous thromboembolism and taking warfarin, according to data published in JAMA Network Open.